Hepatocyte nuclear factor-1beta: Difference between revisions
Jump to navigation
Jump to search
+bladder |
|||
| (5 intermediate revisions by the same user not shown) | |||
| Line 8: | Line 8: | ||
Note: | Note: | ||
*CA-125, RCCma, and CD10 can help distinguish ''clear cell renal cell carcinoma'' and ''Müllerian clear cell tumours''.<ref name=pmid25279712>{{cite journal |authors=Mentrikoski MJ, Wendroth SM, Wick MR |title=Immunohistochemical distinction of renal cell carcinoma from other carcinomas with clear-cell histomorphology: utility of CD10 and CA-125 in addition to PAX-2, PAX-8, RCCma, and adipophilin |journal=Appl Immunohistochem Mol Morphol |volume=22 |issue=9 |pages=635–41 |date=October 2014 |pmid=25279712 |doi=10.1097/PAI.0000000000000004 |url=}}</ref> | *CA-125, RCCma, and CD10 can help distinguish ''clear cell renal cell carcinoma'' and ''Müllerian clear cell tumours''.<ref name=pmid25279712>{{cite journal |authors=Mentrikoski MJ, Wendroth SM, Wick MR |title=Immunohistochemical distinction of renal cell carcinoma from other carcinomas with clear-cell histomorphology: utility of CD10 and CA-125 in addition to PAX-2, PAX-8, RCCma, and adipophilin |journal=Appl Immunohistochem Mol Morphol |volume=22 |issue=9 |pages=635–41 |date=October 2014 |pmid=25279712 |doi=10.1097/PAI.0000000000000004 |url=}}</ref> | ||
===Occasionally positive=== | |||
*[[Lung adenocarcinoma]].<ref name=pmid30065837/> | |||
*[[Prostate adenocarcinoma]].<ref name=pmid30065837/> | |||
*Gastroesophageal adenocarcinoma.<ref name=pmid30065837/> | |||
*Bladder urothelial carcinoma ~40% positive.<ref>{{cite journal |authors=Yang MX, Coates RF, Ambaye A, Gardner JA, Zubarick R, Gao Y, Skelly J, Liu JG, Mino-Kenudson M |title=Investigation of HNF-1B as a diagnostic biomarker for pancreatic ductal adenocarcinoma |journal=Biomark Res |volume=6 |issue= |pages=25 |date=2018 |pmid=30065837 |pmc=6062876 |doi=10.1186/s40364-018-0139-6 |url=}}</ref> | |||
==Negative== | ==Negative== | ||
*[[Serous carcinoma of the ovary]]. | *[[Serous carcinoma of the ovary]]. | ||
*[[Hepatocellular carcinoma]].<ref name=pmid30065837/> | |||
*[[Colorectal adenocarcinoma]].<ref name=pmid30065837/> | |||
*[[Breast adenocarcinoma]].<ref name=pmid30065837/> | |||
*[[Lung squamous cell carcinoma]].<ref name=pmid30065837/> | |||
==References== | ==References== | ||
{{Reflist| | {{Reflist|2}} | ||
[[Category:Immunohistochemistry]] | [[Category:Immunohistochemistry]] | ||